Dealing with 'Brexit' is the simply the "cost of doing business" according to Eisai's regional head Gary Hendler. …
Eisai's Gary Hendler: Dealing with Brexit 'the cost of doing business'
January 24, 2019 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
New Liberal leader Sussan Ley was responsible for major PBS reforms
May 13, 2025 - - Latest News -
New administrative order confirms the total move of NDIS to health
May 13, 2025 - - Latest News -
Trump's language on pricing matches Australia's reflex response to PBS criticism
May 13, 2025 - - Latest News -
Health stakeholders welcome the reappointment of Mark Butler
May 12, 2025 - - Latest News -
Pharma stocks rise in response to Trump's 'MFN' executive order
May 12, 2025 - - Latest News -
Lilly touts weight management results in new head-to-head study
May 12, 2025 - - Latest News -
Experienced industry executive appointed chair of Tryptamine Therapeutics
May 12, 2025 - - Australian Biotech